My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 178

    1.

    The diabetes type 1 locus Idd6 modulates activity of CD4+CD25+ regulatory T-cells.

    Rogner UC, Lepault F, Gagnerault MC, Vallois D, Morin J, Avner P, Boitard C.

    Diabetes. 2006 Jan;55(1):186-92.PMID: 16380492 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

    Gregori S, Giarratana N, Smiroldo S, Adorini L.

    J Immunol. 2003 Oct 15;171(8):4040-7.PMID: 14530324 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.

    Yadav D, Judkowski V, Flodstrom-Tullberg M, Sterling L, Redmond WL, Sherman L, Sarvetnick N.

    J Immunol. 2004 Sep 15;173(6):3631-9.PMID: 15356107 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.

    Ly D, Mi QS, Hussain S, Delovitch TL.

    J Immunol. 2006 Sep 15;177(6):3695-704.PMID: 16951329 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice.

    Chen YG, Scheuplein F, Osborne MA, Tsaih SW, Chapman HD, Serreze DV.

    Diabetes. 2008 Dec;57(12):3273-80. Epub 2008 Sep 5.PMID: 18776136 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

    Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM.

    Diabetes. 2006 Jul;55(7):2098-105.PMID: 16804081 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.

    Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV.

    Cell Immunol. 2005 May;235(1):1-11. Epub 2005 Aug 24.PMID: 16122720 [PubMed - indexed for MEDLINE]Related articles

    8.

    CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.

    Martinez X, Kreuwel HT, Redmond WL, Trenney R, Hunter K, Rosen H, Sarvetnick N, Wicker LS, Sherman LA.

    J Immunol. 2005 Aug 1;175(3):1677-85.PMID: 16034108 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.

    Brode S, Raine T, Zaccone P, Cooke A.

    J Immunol. 2006 Nov 15;177(10):6603-12.PMID: 17082572 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.

    Glinka Y, Chang Y, Prud'homme GJ.

    Mol Ther. 2006 Oct;14(4):578-87. Epub 2006 Jun 21.PMID: 16790365 [PubMed - indexed for MEDLINE]Related articles

    11.

    The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.

    Szanya V, Ermann J, Taylor C, Holness C, Fathman CG.

    J Immunol. 2002 Sep 1;169(5):2461-5.PMID: 12193715 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The type 1 diabetes locus Idd6 controls TLR1 expression.

    Vallois D, Grimm CH, Avner P, Boitard C, Rogner UC.

    J Immunol. 2007 Sep 15;179(6):3896-903.PMID: 17785827 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

    Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM.

    J Exp Med. 2004 Jun 7;199(11):1467-77.PMID: 15184500 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.

    Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.

    Ann N Y Acad Sci. 2005 Jun;1051:72-87. Review.PMID: 16126946 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.

    Harnaha J, Machen J, Wright M, Lakomy R, Styche A, Trucco M, Makaroun S, Giannoukakis N.

    Diabetes. 2006 Jan;55(1):158-70.PMID: 16380489 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Low rate of proliferation in immature thymocytes of the non-obese diabetic mouse maps to the Idd6 diabetes susceptibility region.

    Bergman ML, Penha-Gonçalves C, Lejon K, Holmberg D.

    Diabetologia. 2001 Aug;44(8):1054-61.PMID: 11484085 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes.

    Every AL, Kramer DR, Mannering SI, Lew AM, Harrison LC.

    J Immunol. 2006 Apr 15;176(8):4608-15.PMID: 16585551 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo.

    Weber SE, Harbertson J, Godebu E, Mros GA, Padrick RC, Carson BD, Ziegler SF, Bradley LM.

    J Immunol. 2006 Apr 15;176(8):4730-9.PMID: 16585566 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells.

    Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F.

    Diabetes. 2005 Jan;54(1):78-84.PMID: 15616013 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity